Literature DB >> 3230041

Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver.

F Klimek1, M A Moore, E Schneider, P Bannasch.   

Abstract

A new method for the histochemical demonstration of pyruvate kinase (PK) activity was developed using a semi-permeable membrane and ATP-dependent phosphorylation of glucose coupled with tetrazolium reduction via glucose-6-phosphate dehydrogenase (G6PD) in order to investigate normal liver tissue and neoplastic hepatic nodules induced by thioacetamide (TAA). A series of control reactions and comparison with microbiochemical analysis of microdissected lyophilised material were used to determine the specificity of the reaction. In agreement with earlier reports, an activity gradient in control liver decreasing from zone 3 to zone 1 was apparent both histochemically and after biochemical analysis. Liver neoplastic nodules induced by 25 weeks dietary thioacetamide administration and characterized by increased G6PD demonstrated a clear decrease in PK activity. In contrast, epithelial cells within areas of cholangiocellular tumour development were characterized by a strong increase. Comparison of the results with immunohistochemical and biochemical data from the literature indicate that the specific histochemical method described will be of great assistance in future assessment of disease and physiological alteration in activity of this key enzyme of glycolysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3230041     DOI: 10.1007/bf00495704

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  35 in total

1.  P 1 ,P 5 -Di(adenosine-5')pentaphosphate, a potent multisubstrate inhibitor of adenylate kinase.

Authors:  G E Lienhard; I I Secemski
Journal:  J Biol Chem       Date:  1973-02-10       Impact factor: 5.157

2.  Influence of phosphorylation on the interaction of effectors with rat liver pyruvate kinase.

Authors:  M R El-Maghrabi; T H Claus; M M McGrane; S J Pilkis
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

3.  Distribution of L- and M-type pyruvate kinase between parenchymal and Kupffer cells of rat liver.

Authors:  T J van Berkel; J F Koster; W C Hülsmann
Journal:  Biochim Biophys Acta       Date:  1972-08-28

4.  Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat liver.

Authors:  G Fischer; I Ruschenburg; E Eigenbrodt; N Katz
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver.

Authors:  S Vaulont; A Munnich; J F Decaux; A Kahn
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

6.  Molecular cloning of DNA complementary to rat L-type pyruvate kinase mRNA. Nutritional and hormonal regulation of L-type pyruvate kinase mRNA concentration.

Authors:  T Noguchi; H Inoue; H L Chen; K Matsubara; T Tanaka
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

7.  Evaluation of a histologic classification of mouse liver tumors based on pyruvate kinase isozymes and status of host lipids.

Authors:  S Yanagi; H Tsuda; M Sakamoto; Y Ninomiya; N Ito
Journal:  J Natl Cancer Inst       Date:  1984-12       Impact factor: 13.506

8.  Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters.

Authors:  W Thamavit; R Kongkanuntn; D Tiwawech; M A Moore
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1987

9.  Loss of adenylate cyclase activity in preneoplastic and neoplastic lesions induced in rat liver by N-nitrosomorpholine.

Authors:  V Ehemann; D Mayer; H J Hacker; P Bannasch
Journal:  Carcinogenesis       Date:  1986-04       Impact factor: 4.944

10.  Pyruvate kinase isoenzymes in altered foci and carcinoma of rat liver.

Authors:  M Reinacher; E Eigenbrodt; U Gerbracht; G Zenk; I Timmermann-Trosiener; P Bentley; F Waechter; R Schulte-Hermann
Journal:  Carcinogenesis       Date:  1986-08       Impact factor: 4.944

View more
  4 in total

Review 1.  Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone.

Authors:  P Bannasch; F Klimek; D Mayer
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

2.  Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern.

Authors:  F Dombrowski; E Filsinger; P Bannasch; U Pfeifer
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

3.  Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas.

Authors:  Y S Ahn; A Rempel; H Zerban; P Bannasch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis.

Authors:  H Zerban; H M Rabes; P Bannasch
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.